Record #64827
Development of novel anti-Kv 11.1 antibody-conjugated PEG–TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells
Publisher
Original paper date
Nov 16, 2013
Original DOI
Notes from Retraction Watch
see also: https://mis.cnrs.fr/wp-content/uploads/2025/05/Recommandations.pdf
Citation lifecycle
How this paper is being cited
Pre-retraction
28
Same day
0
Post-retraction
4
% post-retraction
12.5%
~3.2 citations/yr before retraction · ~1.0 citations/yr after
— citing papers
Who is still citing this work
Loading…